Journal of Surgery and Anesthesia

Pharmacological Principles and Clinical Behaviour of Anaesthetic Agents

Isabel Hoogma^* Department of Perioperative Sciences, West bridge University of Medical Research, Rotterdam, Netherlands
^*Correspondence: Isabel Hoogma, Department of Perioperative Sciences, West bridge University of Medical Research, Rotterdam, Netherlands, Email:

Received: 27-Feb-2026, Manuscript No. JSA-26-31503; Editor assigned: 02-Mar-2026, Pre QC No. JSA-26-31503 (PQ); Reviewed: 16-Mar-2026, QC No. JSA-26-31503; Revised: 23-Mar-2026, Manuscript No. JSA-26-31503 (R); Published: 30-Mar-2026, DOI: 10.35248/2684-1606.26.10.306

Description

Anesthetic drug pharmacology focuses on how various agents interact with the human body to produce reversible loss of sensation, unconsciousness, muscle relaxation, or analgesia during medical procedures. These agents are used in surgical environments, diagnostic interventions, and intensive care settings where controlled modulation of the nervous system is required. Understanding their pharmacological behaviours helps clinicians select appropriate drugs based on patient condition, procedure type, and safety considerations.

Anesthetic agents are broadly divided into inhalational and intravenous categories, each with distinct chemical properties and physiological actions. Inhalational agents such as sevoflurane, isoflurane are delivered through the respiratory system and absorbed via the lungs into the bloodstream. Their activity is influenced by blood-gas solubility, which determines how quickly onset and recovery occur. Agents with low solubility tend to produce faster induction and quicker recovery due to rapid equilibration between blood and brain tissues.

Intravenous anesthetic drugs include propanol, thiopental, etomidate, and ketamine. These agents act more rapidly because they are directly introduced into the bloodstream. Propanol, for instance, acts on Gamma-Aminobutyric Acid (GABA) receptors, enhancing inhibitory neurotransmission in the central nervous system, leading to sedation and hypnosis. Thiopental, a barbiturate, produces rapid loss of consciousness by depressing neuronal activity. Ketamine operates differently by blocking N-Methyl-D-Aspartate (NMDA) receptors, which results in dissociative anesthesia while maintaining airway reflexes in many cases.

The pharmacokinetics of anesthetic drugs involve absorption, distribution, metabolism, and elimination. Lipid solubility plays a significant role in determining how quickly drugs reach the central nervous system. Highly lipid-soluble agents cross the blood-brain barrier rapidly, producing faster effects. Redistribution from brain tissue to muscle and fat contributes to recovery from anesthesia in many intravenous agents.

Metabolism primarily occurs in the liver through enzymatic pathways, while elimination may involve renal or pulmonary routes depending on the compound.

Pharmacodynamics of anesthetic drugs is concerned with receptor interactions and physiological responses. Most general anesthetics enhance inhibitory pathways or reduce excitatory neurotransmission in the brain. GABA receptor modulation is a common mechanism among many intravenous and inhalational agents. Some drugs also affect ion channels such as sodium, potassium, and calcium channels, altering neuronal excitability. The combined effect leads to unconsciousness, amnesia, and reduced response to surgical stimuli.

Dose-response relationships are important in anesthesia practice. Small variations in dosage can significantly influence depth of anesthesia, respiratory function, and cardiovascular stability. Careful titration is required to maintain an appropriate balance between adequate sedation and physiological safety. Individual patient factors such as age, weight, liver function, and coexisting medical conditions affect drug sensitivity and metabolism.

Drug interactions are also a major consideration in anesthetic pharmacology. Opioids, benzodiazepines, and neuromuscular blocking agents are frequently used alongside primary anesthetic drugs to achieve balanced anesthesia. Opioids such as fentanyl and morphine provide analgesia by binding to opioid receptors in the central nervous system. Benzodiazepines enhance sedative effects through GABA receptor modulation, while neuromuscular blockers act at the neuromuscular junction to produce muscle relaxation.

Cardiovascular effects of anesthetic agents vary depending on the drug class. Some agents reduce systemic vascular resistance and myocardial contractility, leading to decreased blood pressure. Others may maintain cardiovascular stability or cause mild stimulation. Ketamine, for example, often increases heart rate and blood pressure due to sympathetic nervous system activation. In contrast, propanol may produce hypotension through vasodilation and reduced cardiac output.

Respiratory effects are also significant in anesthetic drug use. Many agents depress respiratory drive by acting on brainstem centre responsible for ventilation control. This necessitates careful monitoring and often mechanical ventilation during surgical procedures. Airway management becomes an essential component of anesthesia practice to ensure adequate oxygenation and carbon dioxide elimination.

Adverse reactions to anesthetic drugs can include allergic responses, cardiovascular instability, respiratory depression, and, in rare cases, malignant hyperthermia. Monitoring systems in operating rooms are designed to detect early physiological changes and allow prompt intervention. Continuous evaluation of oxygen saturation, heart rate, blood pressure, and end-tidal carbon dioxide levels is standard practice.

Continuous research in this field contributes to improved understanding of drug interactions, receptor mechanisms, and physiological responses. These insights help refine clinical protocols and enhance patient safety during surgical and diagnostic procedures.